{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:06:24Z","timestamp":1762956384468,"version":"3.44.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Anestesiolog\u00eda y Reanimaci\u00f3n"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.redar.2020.04.009","type":"journal-article","created":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T07:39:13Z","timestamp":1592206753000},"page":"1-4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hidroxietilalmid\u00f3n, 2020"],"prefix":"10.1016","volume":"68","author":[{"given":"M.","family":"Basora Macaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Jover Pinillos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ripoll\u00e9s-Melchor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.redar.2020.04.009_bib0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa070716","article-title":"Intensive insulin therapy and pentastarch resuscitation in severe sepsis","volume":"358","author":"Brunkhorst","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1016\/j.redar.2020.04.009_bib0135","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1204242","article-title":"Hydroxyethyl starch 130\/0.42 versus Ringer's acetate in severe sepsis","volume":"367","author":"Perner","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1016\/j.redar.2020.04.009_bib0140","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa1209759","article-title":"Hydroxyethyl starch or saline for fluid resuscitation in intensive care","volume":"367","author":"Myburgh","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1016\/j.redar.2020.04.009_bib0145","first-page":"1039","article-title":"Colloidophobia","volume":"82","author":"Ripolles-Melchor","year":"2016","journal-title":"Minerva Anestesiol."},{"key":"10.1016\/j.redar.2020.04.009_bib0150","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/11358","article-title":"Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130\/0.4 vs 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study","volume":"16","author":"Guidet","year":"2012","journal-title":"Crit Care."},{"key":"10.1016\/j.redar.2020.04.009_bib0155","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1001\/jama.2013.280502","article-title":"Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: The CRISTAL randomized trial","volume":"310","author":"Annane","year":"2013","journal-title":"JAMA."},{"key":"10.1016\/j.redar.2020.04.009_bib0160","unstructured":"Hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients [consultado 12 Mar 2020]. Disponible en: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/hydroxyethyl-starch-solutions-infusion"},{"key":"10.1016\/j.redar.2020.04.009_bib0165","unstructured":"European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. Retrospective drug utilisation study to investigate the routine use of hydroxyethyl starch (HES) containing infusion solutions in hospital 2017 [consultado 12 Mar 2020]. Disponible en: http:\/\/www.encepp.eu\/encepp\/viewResource.htm?id=24380"},{"key":"10.1016\/j.redar.2020.04.009_bib0170","unstructured":"European Medicines Agency. PRAC Recommends Suspending Hydroxyethyl-Starch Solutions for Infusion From the Market [consultado 12 Mar 2020]. Disponible en: https:\/\/www.ema.europa.eu\/en\/news\/prac-recommends-suspending-hydroxyethyl-starch-solutions-infusion-market"},{"key":"10.1016\/j.redar.2020.04.009_bib0175","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/aas.13120","article-title":"The SSAI fully supports the suspension of hydroxyethyl-starch solutions commissioned by the European Medicines Agency","volume":"62","author":"Laake","year":"2018","journal-title":"Acta Anaesthesiol Scand."},{"key":"10.1016\/j.redar.2020.04.009_bib0180","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0140-6736(18)30255-1","article-title":"Hydroxyethyl starch solutions and patient harm","volume":"391","author":"Roberts","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.redar.2020.04.009_bib0185","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0140-6736(18)30254-X","article-title":"EMA recommendation to suspend HES is hazardous","volume":"391","author":"Annane","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.redar.2020.04.009_bib0190","unstructured":"Deutsche Gesellschaft f\u00fcr An\u00e4sthesiologie und lntensivmedizin e.V. (DGAI). Open letter to the European Commission: Marketing Authorization of Colloid Solutions Containing Hydroxyethyl Starch (HES) (2018) [consultado 12 Mar 2020]. Disponible en: https:\/\/www.dgai.de\/alle-docman-dokumente\/aktuelles\/794-hes-open-letter-ec.html"},{"key":"10.1016\/j.redar.2020.04.009_bib0195","unstructured":"European Commission Directorate-General for Health and Food Safety. Meeting of the Standing Committee On Medical Products For Human Use Held in Brussels on 9 April 2018 (2018) [consultado 12 Mar 2020]. Disponible en: http:\/\/ec.europa.eu\/transparency\/regcomitology\/index.cfm?do=Search.getPDF&ds_id=56176&version=1&AttLang=en&db_number=1&docType=SUMMARY_RECORD"},{"key":"10.1016\/j.redar.2020.04.009_bib0200","unstructured":"European Medicines Agency. Meeting Highlights From the Pharmacovigilance Risk Assessment Committee (PRAC), 14-17 May 2018 [consultado 12 Mar 2020]. Disponible en: http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl= pages\/news_and_events\/news\/2018\/05\/news_detail_002954.jsp&mid= WC0b01ac058004d5c1"},{"key":"10.1016\/j.redar.2020.04.009_bib0205","unstructured":"European Medicines Agency. Assessment Report Referral Under Article 107i of Directive 2001\/83\/EC Resulting From Pharmacovigilance Data [consultado 12 Mar 2020]. Disponible en: https:\/\/www.ema.europa.eu\/en\/documents\/referral\/hydroxyethyl-starch-article-107i-referral-assessment-report_en.pdf"},{"key":"10.1016\/j.redar.2020.04.009_bib0210","unstructured":"Safety and Efficacy of a 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Trauma Patients (TETHYS) [consultado 12 Mar 2020]. Disponible en: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03338218?term=Hydroxyethyl+Starch+Solution&recrs=a&draw=2&rank=3"},{"key":"10.1016\/j.redar.2020.04.009_bib0215","unstructured":"Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery [consultado 12 Mar 2020]. Disponible en: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03278548?term=Hydroxyethyl+Starch+Solution&recrs=a&draw=2&rank=2"},{"key":"10.1016\/j.redar.2020.04.009_bib0220","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.redar.2015.06.013","article-title":"Clinical practice guide for the choice of perioperative volume-restoring fluid in adult patients undergoing non-cardiac surgery","volume":"63","author":"Basora","year":"2016","journal-title":"Rev Esp Anestesiol Reanim."},{"key":"10.1016\/j.redar.2020.04.009_bib0225","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/EJA.0000000000000447","article-title":"Intravascular volume therapy in adults: Guidelines from the Association of the Scientific Medical Societies in Germany","volume":"33","author":"Marx","year":"2016","journal-title":"Eur J Anaesthesiol."},{"key":"10.1016\/j.redar.2020.04.009_bib0230","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1097\/ALN.0000000000002413","article-title":"Morbidity and mortality of crystalloids compared to colloids in critically ill surgical patients: A subgroup analysis of a randomized trial","volume":"129","author":"Heming","year":"2018","journal-title":"Anesthesiology."},{"key":"10.1016\/j.redar.2020.04.009_bib0235","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/ALN.0000000000002501","article-title":"Long-term impact of crystalloid versus colloid solutions on renal function and disability-free survival after major abdominal surgery","volume":"130","author":"Joosten","year":"2019","journal-title":"Anesthesiology."},{"key":"10.1016\/j.redar.2020.04.009_bib0240","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/ALN.0000000000002601","article-title":"Crystalloid-colloid study team effect of intraoperative goal-directed balanced crystalloid versus colloid administration on major postoperative morbidity: A randomized trial","volume":"130","author":"Kabon","year":"2019","journal-title":"Anesthesiology."},{"key":"10.1016\/j.redar.2020.04.009_bib0245","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jama.2019.20833","article-title":"Effect of hydroxyethyl starch vs saline for volume replacement therapy on death or postoperative complications among high-risk patients undergoing major abdominal surgery: The FLASH randomized clinical trial","volume":"323","author":"Futier","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.redar.2020.04.009_bib0250","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.redar.2018.12.007","article-title":"[Fluid therapy in the surgical patient in our environment. Reporting on the Fluid Day Study]","volume":"66","author":"Colomina","year":"2019","journal-title":"Rev Esp Anestesiol Reanim."}],"container-title":["Revista Espa\u00f1ola de Anestesiolog\u00eda y Reanimaci\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034935620301158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034935620301158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:24:09Z","timestamp":1758518649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034935620301158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0034935620301158"],"URL":"https:\/\/doi.org\/10.1016\/j.redar.2020.04.009","relation":{},"ISSN":["0034-9356"],"issn-type":[{"type":"print","value":"0034-9356"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidroxietilalmid\u00f3n, 2020","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Anestesiolog\u00eda y Reanimaci\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redar.2020.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedad Espa\u00f1ola de Anestesiolog\u00eda, Reanimaci\u00f3n y Terap\u00e9utica del Dolor. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}